The rapid evolution of omic technologies such as spanning genomics, transcriptomics, and proteomics, is reshaping how we ...
Antimicrobial resistance (AMR) research has become a major focus of global health and evolutionary bioinformatics. Despite ...
For patients with acute myeloid leukemia (AML) who are 75 years of age or older or who are ineligible for intensive induction chemotherapy, azacitidine or decitabine plus venetoclax is the standard of ...
Clinical benefits of early-phase clinical trials for rare malignancies: Asian single-center analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not ...
The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy. The combination of decitabine-cedazuridine ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved the oral combination of decitabine/cedazuridine tablets with venetoclax for certain adults ...
Abstract: Acute Myeloid Leukemia (AML) is a highly heterogeneous hematological malignancy with poor prognosis, necessitating the identification of reliable biomarkers for early diagnosis and targeted ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
FinCEN has proposed reforming AML/CFT programs to reduce compliance burdens and focus on effectiveness rather than paperwork. The rule would give institutions more flexibility in risk-based design and ...
US regulators unveiled a plan Tuesday to overhaul rules intended to prevent money laundering, a move likely to be cheered by Wall Street as banks continue to rack up wins in their push for policy ...
The former chairman of a financial group was brought to China in handcuffs, the latest high-level capture in a widening investigation into organized crime. By Selam Gebrekidan China nabbed on ...